Katherine E. McGoogan, MD
PhysicianBiography
Katherine McGoogan is a pediatric gastroenterologist with a focus in pediatric hepatology. Her career focus has mainly been as a clinician. She participates in clinical research in pediatric gastroenterology including clinical trials in infant formula, medications for constipation/IBS-C, inflammatory bowel disease, and Zellweger's syndrome. Her clinical interests are in Hepatitis C, biliary atresia, and Alagille syndrome.
Fellowship
- Pediatric Gastroenterology - University of Florida College of Medicine, 2011
Internship Residency
- Pediatrics - Duke University Medical Center, 2008
Medical/Dental School
- MD - University of Miami School of Medicine, 2005
- Bachelor of Arts University of Miami
Board Certifications
- American Board of Pediatrics/Gastroenterology
-
Energy- and protein-enriched formula improves weight gain in infants with malnutrition due to cardiac and noncardiac etiologies.; JPEN. Journal of parenteral and enteral nutrition; (2022).
View Full Publication -
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.; American journal of human genetics; (2021).
View Full Publication -
Neonatal gastric lactobezoar: management with N-acetylcysteine.; Case reports in pediatrics; (2012).
View Full Publication -
Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.; Gene therapy; (2011).
View Full Publication -
High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors. ; Journal of visualized experiments : JoVE; (2011).
View Full Publication -
Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity.; The Journal of pediatrics; (2011).
View Full Publication -
Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis.; Journal of pediatric gastroenterology and nutrition; (2010).
View Full Publication -
Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3.; Human gene therapy; (2010).
View Full Publication